Multimodality treatment for non melanoma skin cancer: a prospective study done on 120 egyptian patients.
Multiple currently accepted treatments for non melanoma skin cancer (NMSC) are now available. To present multimodality treatment for NMSCs and to report any side effects or recurrence during three years follow-up period. This is a prospective study including 120 patients with NMSCs. Patients were subjected to different treatment modalities with follow-up for three years. 103 Patients (85.8%) were treated by surgery with or without post operative radiotherapy, 8 patients (5%) received only radiation therapy, 7 patients (5.8%) treated by shave excision followed by medical treatment (intralesional interferon for 3 months, systemic retinoids and cyclo-oxygenase inhibitor for 6 months), and 2 patients (1.7%) escaped the treatment. All patients treated by shave excision followed by medical treatment showed complete healing of all lesions 6 months after completing the course of treatment. Alternatives to the surgical management of NMSC may be preferred under certain circumstances. BCC - Interferon - Retinoids - SCC.